Open access
Oct 2026
Recurrence of cardiovascular events despite achieving LDL-C <1.4 mmol/L i in patients with coronary artery disease
Given the association of on-treatment LDL-C <40 mg/dL with a reduced risk of MACE, further lower LDL-C level may be more favourable therapeutic goal for the secondary prevention of ASCVD in patients with CAD.
Y. Kataoka, S. Nicholls, S. Kitahara et al.
· European Heart Journal · 0 citations